New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
10:10 EDTACMP, CCE, COV, GNC, NCLH, RNR, TMHOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Access Midstream (ACMP) downgraded to Neutral from Buy at BofA/Merrill... Coca-Cola Enterprises (CCE) downgraded to Buy from Conviction Buy at Goldman... Covidien (COV) downgraded to Fair Value from Buy at CRT Capital... GNC Holdings (GNC) downgraded to Neutral from Outperform at RW Baird... Norwegian Cruise Line (NCLH) downgraded to Neutral at SunTrust... RenaissanceRe (RNR) downgraded at JMP Securities... Team Health (TMH) downgraded to Buy from Conviction Buy at Goldman.
News For ACMP;CCE;COV;GNC;NCLH;RNR;TMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 23, 2014
16:20 EDTCOVOn The Fly: Closing Wrap
Stocks on Wall Street were lower after the U.S. took new action to clamp down on tax inversion deals and led airstrikes against Islamic State militants in Syria, while Europe reported weaker than expected manufacturing data. ECONOMIC EVENTS: In the U.S., the FHFA's home price index rose 0.1% in July to 212.7, missing expectations for an increase of 0.5%. Markit's preliminary manufacturing Purchasing Managers' Index for September came in at 57.9, slightly below the consensus forecast for a 58.0 reading. In China, HSBC's flash manufacturing PMI rose to 50.5 from a final reading of 50.2 in August, better than expectations. In Europe, Markit's composite flash PMI for the eurozone dipped to a nine-month low of 52.3, missing expectations for it to hold steady with its 52.5 reading for August. COMPANY NEWS: The shares of a number of companies that have announced or been speculated as targets in tax inversion deals fell after the U.S. Treasury last night issued new regulations that will make such deals less attractive. AstraZeneca (AZN), which has previously turned down an offer to be acquired by the U.S.'s Pfizer (PFE), sank $3.54, or 4.74%, to $71.13 despite a Bloomberg report that said Pfizer is still considering pursuing a deal with the U.K. drugmaker. AbbVie (ABBV), which has a deal in progress to acquire Shire (SHPG) and thus move its tax domicile to Ireland, fell $1.15, or 1.96%, to $57.56, while Shire shares slid $5.56, or 2.17%, to $250.74. Medtronic (MDT), which is pursuing its own inversion deal with Covidien (COV), dropped $1.90, or 2.88%, to $64.08. MAJOR MOVERS: Among the notable gainers was Herbalife (HLF), which rose $3.88, or 9.65%, to $44.09, bouncing back from a pullback yesterday that had been attributed to rumors of Carl Icahn selling out of his stake in the company. Also higher was Plug Power (PLUG), which rose 40c, or 9.57%, to $4.58 after the company's CEO gave FY15 revenue guidance that was above the consensus Street view in an interview with the Albany Business Review. Among the noteworthy losers was Ascena Retail (ASNA), which dropped $2.78, or 16.82%, to $13.75 after the apparel retailer's fourth quarter results and fiscal 2015 profit outlook trailed analysts' consensus estimates. Also lower were shares of used car retailer CarMax (KMX), which fell $5.01, or 9.49%, to $47.80 after the company reported sluggish comparable used car sales in its second quarter. INDEXES: The Dow declined 116.81, or 0.68%, to 17,055.87, the Nasdaq dropped 19.00, or 0.42%, to 4,508.69, and the S&P 500 fell 11.52, or 0.58%, to 1,982.77.
12:11 EDTCOVOn The Fly: Midday Wrap
Stocks on Wall Street were mixed and little changed at midday, amid new rules from the Obama administration on tax inversions and manufacturing data from around the globe. ECONOMIC EVENTS: In the U.S., the FHFA's home price index rose 0.1% in July to 212.7, missing expectations for a rise of 0.5%. Markit's preliminary manufacturing Purchasing Managers' Index for September came in at 57.9, slightly below the consensus forecast for a 58.0 reading. The Richmond Fed manufacturing index for September rose to 14, beating expectations for it to have dropped two points to 10. In China, HSBC's flash manufacturing Purchasing Managers' Index rose to 50.5 from a final reading of 50.2 in August, better than expectations. In Europe, Markit's composite flash PMI for the eurozone dipped to a nine-month low of 52.3, missing expectations for it to hold steady at the 52.5 seen in August. COMPANY NEWS: Shares of several companies, including a number in the pharmaceutical industry, are lower in early trading after the Treasury Department announced new regulations yesterday night that aim to make it tougher for U.S. companies to lower their tax burdens via mergers with foreign companies, otherwise known as "inversions." Among the stocks that moved lower after the new rules were announced was Astrazeneca (AZN), which had previously been a target of Pfizer (PFE) and fell about 4% near midday. Also lower were shares of both Shire (SHPG), which fell 2%, and Abbvie (ABBV), which dropped 1.6%, as the two have previously agreed to merge in a tax inversion deal. Medtronic (MDT) and Covidien (COV), which similarly agreed to an inversion merger, were down 3.3% and 2.7%, respectively. MAJOR MOVERS: Among the notable gainers was Salix Pharmaceuticals (SLXP), which rose more than 5% after The Wall Street Journal reported that Allergan (AGN) is in advanced talks on a deal to buy the company. Shares of Allergan were also up nearly 3% near midday, as the Journal also reported that Allergan rejected a recent buyout offer from Actavis (ACT). Among the noteworthy losers was Ascena Retail (ASNA), which dropped 16% after the apparel retailer's fourth quarter results and fiscal 2015 profit outlook trailed analysts' consensus estimates. Also lower following its own earnings report was auto retailer CarMax (KMX), which fell over 9%. INDEXES: Near midday, the Dow was down 32.91, or 0.19%, to 17,139.77, the Nasdaq was up 2.90, or 0.06%, to 4,530.59, and the S&P 500 was down 2.29, or 0.11%, to 1,992.00.
10:54 EDTCOVStocks, analysts react to Treasury inversion crackdown
Subscribe for More Information
10:27 EDTNCLHCarnival signs of Caribbean recovery bodes well for peers, says Wells Fargo
Subscribe for More Information
09:13 EDTCOVOn The Fly: Pre-market Movers
Subscribe for More Information
08:53 EDTCOVInversion regulations look more onerous than expected, says FBR Capital
FBR Capital says the new regulations announced last night by the Treasury and IRS contain appear more onerous than expected. FBR points out the proposed changes remove the ability of inverting companies to make "hopscotch loans" between the foreign and domestic subsidiaries. The firm believes the regulations will not end the practice of inversions, and it still expects completion of already announced deals.
07:05 EDTCOVMedtronic will still pursue Covidien deal, says Citigroup
Subscribe for More Information
05:56 EDTCOVTreasury, IRS announce plans to reduce inversion tax benefits
Subscribe for More Information
September 22, 2014
07:15 EDTNCLHNorwegian Cruise Line pricing improving, says Wells Fargo
Subscribe for More Information
September 19, 2014
11:25 EDTCOVSenators bring bill requiring companies to settle before inverting
U.S. Senators Sherrod Brown and Dick Durbin announced new legislation requiring corporations to "Pay What You Owe Before You Go" – settling their U.S. tax bill before relocating to a foreign country. "Everyone knows that before you leave a restaurant you have to settle your tab," Brown said. "Corporations shouldn’t get to play by different rules. While it is critical that we reach a long-term solution that reforms our international corporate tax code by implementing a global minimum tax and reducing the statutory tax rate, this bill is an immediate, commonsense measure to ensure businesses settle up before leaving the U.S." Among the deals or possible transactions that involve inversion are Mylan's (MYL) acquisition of Abbott (ABT), Medtronic's (MDT) acquisition of Covidien (COV) and Valeant's (VRX) proposed takeover of Allergan (AGN).
09:16 EDTGNCGNC Holdings price target raised to $47 from $36 at Sterne Agee
Subscribe for More Information
September 18, 2014
17:00 EDTGNCGNC Holdings considering sale after receiving private equity interest, FT says
Subscribe for More Information
16:11 EDTGNCGNC Holdings appoints Daisy Vanderlinde as Chief Human Resource Officer
GNC Holdings (GNC) announced the addition of Daisy Vanderlinde as Chief Human Resource Officer. Vanderlinde comes to GNC most recently from Office Depot, where she was Executive Vice President of Human Resources (ODP).
16:09 EDTGNCGNC Holdings appoints Jeffrey Hennion as Chief Marketing and eCommerce Officer
GNC Holdings announced the addition Jeffrey R. Hennion as executive vice president, Chief Marketing and eCommerce Officer. Hennion comes to GNC most recently from Branding Brand, where he served as CFO.
15:48 EDTGNCGNC considering options after receive PE interest, FT says
Subscribe for More Information
15:09 EDTGNCVitamin Shoppe holders urge exploration of sale to GNC or pe firm, Reuters says
Subscribe for More Information
September 17, 2014
16:01 EDTCOVCovidien raises quarterly dividend to 36c from 32c
Subscribe for More Information
10:00 EDTGNCOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AB InBev (BUD) upgraded to Hold from Sell at Societe Generale... Baker Hughes (BHI) upgraded to Outperform from Sector Perform at Howard Weil... Bank of the Ozarks (OZRK) upgraded to Buy from Hold at BB&T... Bill Barrett (BBG) upgraded to Buy from Neutral at Mizuho... Cepheid (CPHD) upgraded to Buy from Hold at Cantor... Cigna (CI) upgraded to Positive from Neutral at Susquehanna... Extra Space Storage (EXR) upgraded to Buy from Hold at Jefferies... GNC Holdings (GNC) upgraded to Outperform from Neutral at Wedbush... MB Financial (MBFI) upgraded at DA Davidson... Mondelez (MDLZ) upgraded to Buy from Hold at Societe Generale... Radian Group (RDN) upgraded to Buy from Neutral at Compass Point... Skullcandy (SKUL) assumed with a Overweight from Neutral at Piper Jaffray... Under Armour (UA) upgraded to Overweight from Neutral at Piper Jaffray.
09:00 EDTGNCGNC Holdings estimates cut 'well below' consensus at William Blair
William Blair lowered its estimates for GNC Holdings "well below" the current consensus after taking down its 2014 earnings estimate by 5c to $2.65 and 2015 estimate by 10c to $2.90. The firm finds it "tough to identify" any improvement in operating trends during Q3, and feels the departure of four key executives in the last three months suggests "deeper fundamental issues" for the company. William Blair lists large overlap in product assortment with Amazon (AMZN) and buy-one-get-one promotional activity continuing in Q3 as reasons for concern. The firm reiterates an Underperform rating on GNC and notes the stock is up nearly 20% since the Q2 release.
07:01 EDTGNCGNC Holdings upgraded to Outperform from Neutral at Wedbush
Wedbush upgraded GNC Holdings to Outperform following store checks that indicate stabilizing trends with a reduction in promotional activity. The firm believes GNC Holdings' reduced guidance in July is realistic and that re-franchising company-owned stores will be viewed positively by investors. Price target raised to $46 from $34.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use